Atlas Trials

Post Kala-Azar Dermal Leishmaniasis

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Post Kala-Azar Dermal Leishmaniasis

RecordFirmDate
Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan (NCT05449717)Epicentre2022-05-31
Miltefosine for Children With PKDL (NCT02193022)International Centre for Diarrhoeal Disease Research, Bangladesh2014-07-01
Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh (NCT03311607)Medecins Sans Frontieres, Netherlands2014-04-08
A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) (NCT01975051)International Centre for Diarrhoeal Disease Research, Bangladesh2013-01-01
Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL (NCT00982774)Access to Advanced Health Institute (AAHI)2009-04-01
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India (NCT00486382)Access to Advanced Health Institute (AAHI)2007-04-01

Track Post Kala-Azar Dermal Leishmaniasis automatically

Every clearance here is in the API, with alerts when new ones post.